Psychedelic medicine has gone mainstream. Who will benefit?
MAPS is currently studying MDMA-assisted psychotherapy as a method of treating PTSD. The clinical trials are in Phase 3, the last stage before approval from the U.S. Food and Drug Administration, and MAPS, which has been working toward this moment since its inception as a research and advocacy organization in 1986, has been preparing for … Read more